Light-activated medical implants
Nature Photonics
2013년10월21일
Matchstick-sized, transparent polymer implants containing synthetic cells that are genetically modified to activate in response to light can provide specific and local in-body therapies to mice, according to a report published online in Nature Photonics. Such implants could be important for a wide range of diagnostic and therapeutic applications, such as an optical treatment for diabetes or real-time monitoring of toxins in the body.
As a first demonstration of the medical utility of such light-activated implants, Seok Yun and colleagues regulate blood glucose levels in diabetic mice. They used blue light supplied through an optical fibre to the implant, to induce the cells in the implant to synthesize a protein that stimulates insulin production. In another demonstration, the team created implants with cells that emit green light when stressed by the presence of certain toxins such as heavy metals. By measuring light levels emitted by the implant, such implants in the future could be used as sensors for monitoring toxin levels in patients in real time. The approach works because the implants are both highly transparent and biocompatible.
doi: 10.1038/nphoton.2013.278
리서치 하이라이트
-
6월24일
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
6월17일
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
6월16일
An exercise-inducible molecule that suppresses appetiteNature
-
6월16일
Cancer: Signatures of structural genomic variation in cancerNature
-
6월10일
Animals: Genetic clues to how dogs became man’s best friendsScientific Reports